| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/16/2013 | WO2013068489A1 Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a |
| 05/16/2013 | WO2013068470A1 Inhibitors of phosphodiesterase type 10a |
| 05/16/2013 | WO2013068328A1 Bicyclo [2.2.2] octan-1-ylcarboxylic acid compounds as dgat-1 inhibitors |
| 05/16/2013 | WO2013068275A1 Polymer-bonded polycyclic aromatic hydrocarbons having nitrogen containing substituents |
| 05/16/2013 | WO2013067710A1 Nampt inhibitors |
| 05/16/2013 | WO2013067597A1 Immunomodulatory conjugates |
| 05/16/2013 | US20130123297 Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative |
| 05/16/2013 | US20130123296 Lonidamine analogues for fertility management |
| 05/16/2013 | US20130123288 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 05/16/2013 | US20130123284 Heterocyclic compounds useful for kinase inhibition |
| 05/16/2013 | US20130123277 Pyrido[3,4-b]indoles and methods of use |
| 05/16/2013 | US20130123271 Heterocyclic compounds, their preparation and therapeutic application |
| 05/16/2013 | US20130123256 Pyrazolo Pyridine Derivatives as NADPH Oxidase Inhibitors |
| 05/16/2013 | US20130123250 Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as nk1 tachikynin receptor antagonists |
| 05/16/2013 | US20130123244 Hetero-Bicyclic Derivatives as HCV Inhibitors |
| 05/16/2013 | US20130123242 Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/16/2013 | US20130123241 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 05/16/2013 | US20130123237 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 05/16/2013 | US20130123236 Substituted benzylspiroindolin-2-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| 05/16/2013 | US20130123232 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 05/16/2013 | US20130123215 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/16/2013 | US20130121994 Triazolopyridine derivatives |
| 05/16/2013 | CA2855510A1 Nampt inhibitors |
| 05/16/2013 | CA2855204A1 Pharmaceutical compounds |
| 05/16/2013 | CA2855004A1 Nadph oxidase 4 inhibitors and use thereof |
| 05/16/2013 | CA2854622A1 Modulators of opioid receptors and methods of use thereof |
| 05/16/2013 | CA2853203A1 Polymer-bonded polycyclic aromatic hydrocarbons having nitrogen containing substituents |
| 05/16/2013 | CA2853024A1 2-thiopyrimidinones |
| 05/16/2013 | CA2852820A1 Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a |
| 05/16/2013 | CA2852604A1 Inhibitors of phosphodiesterase type 10a |
| 05/15/2013 | EP2592905A1 Compound, charge transporting material and organic electroluminescent element |
| 05/15/2013 | EP2592082A1 Heteroaryl amide analogues as p2x7 antagonists |
| 05/15/2013 | EP2592081A1 Tetrahydrocarboline derivative |
| 05/15/2013 | EP2592080A1 Crystal of fused pyridine compound salt |
| 05/15/2013 | EP2591782A1 Nadph oxidase 4 inhibitors and use thereof |
| 05/15/2013 | EP2591675A1 Heteroaryl amide derivatives |
| 05/15/2013 | EP2590976A1 Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof |
| 05/15/2013 | EP2590975A1 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof |
| 05/15/2013 | EP2590974A1 Tetrahydro-pyrido-pyrimidine derivatives |
| 05/15/2013 | EP2590960A1 Heterocyclic antiviral compounds |
| 05/15/2013 | EP2590953A1 Tetrazole compounds as calcium channel blockers |
| 05/15/2013 | EP2590950A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 05/15/2013 | EP2590946A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 05/15/2013 | EP2590647A2 Pro-neurogenic compounds |
| 05/15/2013 | CN1863891B Organic compound and organic light emitting device using the same |
| 05/15/2013 | CN103108873A Substituted imidazoquinoline derivatives as kinase inhibitors |
| 05/15/2013 | CN103108871A 17a-hydroxylase/c17,20-lyase inhibitors |
| 05/15/2013 | CN103102352A Tyrosine kinase inhibitor indolinone derivative |
| 05/15/2013 | CN103102344A Aminoquinazoline derivative, salts thereof and application method |
| 05/15/2013 | CN102321083B Preparation method of new anhydrous moxifloxacin hydrochloride crystal F |
| 05/15/2013 | CN101951909B Pyridopyrazinones derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 05/15/2013 | CN101808994B Compounds and methods for kinase modulation, and indications therefor |
| 05/14/2013 | US8440830 Tetrahydro-fused pyridines as histone deacetylase inhibitors |
| 05/14/2013 | US8440829 PI3 kinase/mTOR dual inhibitor |
| 05/14/2013 | US8440828 Organic semiconductors and devices incorporating same |
| 05/14/2013 | US8440689 Fused heteroaromatic pyrrolidinones |
| 05/14/2013 | US8440679 Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors |
| 05/14/2013 | US8440670 Pyridopyrazindione derivative and its use as an antiulcer drug |
| 05/14/2013 | US8440666 Pyridazinone compounds and P2X7 receptor inhibitors |
| 05/14/2013 | CA2731368C 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 05/14/2013 | CA2611889C Substituted tetrahydroquinolines |
| 05/14/2013 | CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/10/2013 | WO2013067434A1 Pak inhibitors for the treatment of fragile x syndrome |
| 05/10/2013 | WO2013067423A1 Pak inhibitors for the treatment of cell proliferative disorders |
| 05/10/2013 | WO2013067277A1 Alkylated piperazine compounds as inhibitors of btk activity |
| 05/10/2013 | WO2013067274A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity |
| 05/10/2013 | WO2013067260A1 Bicyclic piperazine compounds |
| 05/10/2013 | WO2013065712A1 Diazaspirourea derivative and pharmaceutical use thereof |
| 05/10/2013 | WO2013064984A1 Biaryl ether sulfonamides and their use as therapeutic agents |
| 05/10/2013 | WO2013064519A1 Pesticidal compounds |
| 05/10/2013 | WO2013064231A1 SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3) |
| 05/10/2013 | WO2013064206A1 Organic electroluminescent device |
| 05/10/2013 | WO2013006634A3 Processes and intermediates for producing azaindoles |
| 05/10/2013 | WO2013006634A2 Processes and intermediates for producing azaindoles |
| 05/10/2013 | WO2012178015A3 Lrrk2 inhibitors |
| 05/10/2013 | WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors |
| 05/10/2013 | CA2855019A1 Biaryl ether sulfonamides and their use as therapeutic agents |
| 05/10/2013 | CA2854471A1 Pak inhibitors for the treatment of cell proliferative disorders |
| 05/10/2013 | CA2854462A1 Pak inhibitors for the treatment of fragile x syndrome |
| 05/10/2013 | CA2853975A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity |
| 05/10/2013 | CA2853970A1 Alkylated piperazine compounds as inhibitors of btk activity |
| 05/10/2013 | CA2852964A1 Bicyclic piperazine compounds |
| 05/09/2013 | US20130116430 Novel nicotinamide derivative or salt thereof |
| 05/09/2013 | US20130116318 Enzyme Inhibitors |
| 05/09/2013 | US20130116273 Beta carboline derivatives useful in the treatment of proliferative disorders |
| 05/09/2013 | US20130116272 Heterocyclic fused phenanthrolinone m1 receptor positive allosteric modulators |
| 05/09/2013 | US20130116270 Novel compounds |
| 05/09/2013 | US20130116269 Cyclic n,n'-diarylthioureas and n,n'-diarylureas - androgen receptor antagonists, anticancer agent, method for preparation and use thereof |
| 05/09/2013 | US20130116263 Pak inhibitors for the treatment of cell proliferative disorders |
| 05/09/2013 | US20130116262 Bicyclic piperazine compounds |
| 05/09/2013 | US20130116260 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 05/09/2013 | US20130116250 Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof |
| 05/09/2013 | US20130116249 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof |
| 05/09/2013 | US20130116248 Substituted imidazoquinoline derivatives as kinase inhibitors |
| 05/09/2013 | US20130116245 Alkylated piperazine compounds |
| 05/09/2013 | US20130116243 Inhibitors of akt activity |
| 05/09/2013 | US20130116241 Novel inhibitor compounds of phosphodiesterase type 10a |
| 05/09/2013 | US20130116240 Indole compounds and pharmaceutical use thereof |
| 05/09/2013 | US20130116237 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 05/09/2013 | US20130116235 Heteroaryl pyridone and aza-pyridone compounds |